您当前的位置:灵芝酸D

灵芝酸D

时间:2023-07-18  来源:化工号   作者:C30H42O7
中文名 灵芝酸D
英文名 Ganoderic acid D
别名 灵芝酸D
灵芝酸D标准品
灵芝酸D对照品,
英文别名 Ganoderic acid D
(7beta)-7-Hydroxy-3,11,15,23-tetraoxolanost-8-en-26-oic acid
Lanost-8-en-26-oic acid, 7-hydroxy-3,11,15,23-tetraoxo-, (7β)-
CAS 108340-60-9
化学式 C30H42O7
分子量 514.65
密度 1.22±0.1 g/cm3(Predicted)
沸点 688.3±55.0 °C(Predicted)
溶解度 氯仿,甲醇
酸度系数 4.77±0.23(Predicted)
存储条件 2-8℃
外观 白色粉末或结晶
物化性质 白色粉末,可溶于甲醇、乙醇、DMSO等有机溶剂,来源于多孔菌科灵芝Ganodermalucidum(Leyss.exFr.)Karst.的干燥子实体。
MDL号 MFCD29049470
体外研究 Ganoderic acid D can inhibit the growth of numerous cancer cell lines and it inhibits HeLa human cervical carcinoma cells with an IC 50 of 17.3 mM.Ganoderic acid D (1-50 μM; 24-72 hours) reduces the cell survival rate in a dose- and time-dependent manner. Ganoderic acid D (10, 50 μM; 24, 48 hours) induces G2/M phase arrest. Ganoderic acid D (10, 50 μM; 24, 48 hours) induces a morphological change typical of apoptosis in HeLa cells. Ganoderic acid D (10 μM; 48 hours) up-regulates 14-3-3E and PRDX3. Cell Viability Assay Cell Line: HeLa human cervical carcinoma cell line (CCL-2) Concentration: 1, 5, 10, 20, 50 μM Incubation Time: 24, 48, 72 hours Result: Reduced the cell survival rate in a dose- and time-dependent manner and had an IC 50 value of 17.3 μM for 48 hours treatment. Cell Cycle Analysis Cell Line: HeLa human cervical carcinoma cell line (CCL-2) Concentration: 10, 50 μM Incubation Time: 24, 48 hours Result: Induced G2/M phase arrest. Displayed a cell cycle profile with an elevated G2/M cell population after 24-h treatment with 10 μM. Apoptosis Analysis Cell Line: HeLa human cervical carcinoma cell line (CCL-2) Concentration: 10, 50 μM Incubation Time: 48 hours Result: Induced a morphological change typical of apoptosis in HeLa cells. Western Blot Analysis Cell Line: HeLa human cervical carcinoma cell line (CCL-2) Concentration: 10 μM Incubation Time: 48 hours Result: Up-regulated 14-3-3E and PRDX3.
参考资料 展开查看 1. 沐华, 蔡铭, 徐靖,等. 破壁与去壁灵芝孢子粉的化学成分与抗氧化活性比较[J]. 食品工业科技, 2020, 041(010):32-37,51
2. 范蕾, 陈琴鸣, 陈张金,等. 灵芝一测多评质量控制方法的研究[J]. 中国药师, 2018, v.21(05):76-80.
来顶一下
返回首页
返回首页
推荐资讯
热门点击